These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2762329

  • 1. Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
    Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R.
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6358-62. PubMed ID: 2762329
    [Abstract] [Full Text] [Related]

  • 2. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA, Michaeli J, Jackson J, Richon VM, Rifkind RA.
    Prog Clin Biol Res; 1989 Aug; 316B():171-81. PubMed ID: 2616574
    [Abstract] [Full Text] [Related]

  • 3. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
    Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1996 Jun 11; 93(12):5705-8. PubMed ID: 8650156
    [Abstract] [Full Text] [Related]

  • 4. Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.
    Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1988 Jun 11; 85(11):3835-9. PubMed ID: 3163801
    [Abstract] [Full Text] [Related]

  • 5. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process.
    Marks PA, Richon VM, Kiyokawa H, Rifkind RA.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10251-4. PubMed ID: 7937935
    [Abstract] [Full Text] [Related]

  • 6. Cell cycle regulatory proteins are targets for induced differentiation of transformed cells: Molecular and clinical studies employing hybrid polar compounds.
    Marks PA, Richon VM, Rifkind RA.
    Int J Hematol; 1996 Jan 25; 63(1):1-17. PubMed ID: 8713572
    [Abstract] [Full Text] [Related]

  • 7. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA, Rifkind RA.
    Int J Cell Cloning; 1988 Jul 25; 6(4):230-40. PubMed ID: 3047266
    [Abstract] [Full Text] [Related]

  • 8. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
    Michaeli J, Lebedev YB, Richon VM, Chen ZX, Marks PA, Rifkind RA.
    Mol Cell Biol; 1990 Jul 25; 10(7):3535-40. PubMed ID: 1972544
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.
    Richon VM, Weich N, Leng L, Kiyokawa H, Ngo L, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1666-70. PubMed ID: 1672043
    [Abstract] [Full Text] [Related]

  • 10. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
    Weich N, Marks PA, Rifkind RA.
    Blood; 1990 Jul 15; 76(2):302-6. PubMed ID: 2369636
    [Abstract] [Full Text] [Related]

  • 11. Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.
    Melloni E, Pontremoli S, Sparatore B, Patrone M, Grossi F, Marks PA, Rifkind RA.
    Proc Natl Acad Sci U S A; 1990 Jun 15; 87(12):4417-20. PubMed ID: 2352925
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.
    Melloni E, Pontremoli S, Viotti PL, Patrone M, Marks PA, Rifkind RA.
    J Biol Chem; 1989 Nov 05; 264(31):18414-8. PubMed ID: 2808382
    [Abstract] [Full Text] [Related]

  • 13. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.
    Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1998 Mar 17; 95(6):3003-7. PubMed ID: 9501205
    [Abstract] [Full Text] [Related]

  • 14. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
    Wang H, Zhang S, Zhou J, Zhang J.
    Chin Med Sci J; 2002 Mar 17; 17(1):27-31. PubMed ID: 12894881
    [Abstract] [Full Text] [Related]

  • 15. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
    Murate T, Kaneda T, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1984 Jun 17; 81(11):3394-8. PubMed ID: 6203120
    [Abstract] [Full Text] [Related]

  • 16. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.
    Kiyokawa H, Richon VM, Venta-Perez G, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1993 Jul 15; 90(14):6746-50. PubMed ID: 8341693
    [Abstract] [Full Text] [Related]

  • 17. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA, Ramsay R, Sheffery M, Rifkind RA.
    Prog Clin Biol Res; 1987 Jul 15; 251():253-68. PubMed ID: 3481077
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of murine erythroleukemia cells by hexamethylenebisacetamide involves secretion and binding to membranes of a differentiation enhancing factor.
    Sparatore B, Patrone M, Passalacqua M, Melloni E, Pontremoli S.
    Biochem Biophys Res Commun; 1991 Aug 30; 179(1):153-60. PubMed ID: 1883347
    [Abstract] [Full Text] [Related]

  • 19. Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides.
    Chatzopoulou M, Bonovolias ID, Nicolaou I, Demopoulos VJ, Vizirianakis IS, Tsiftsoglou AS.
    Eur J Med Chem; 2012 Apr 30; 50():75-80. PubMed ID: 22341896
    [Abstract] [Full Text] [Related]

  • 20. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX.
    Zhonghua Zhong Liu Za Zhi; 1991 Jul 30; 13(4):261-4. PubMed ID: 1806345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.